Lutikizumab
Product Specifications
CAS Number
1791411-57-8
Target
Interleukin
Related Pathways
Immunology/Inflammation
Bioactivity
Lutikizumab (ABT-981) is a dual variable domain immunoglobulin targeting and inhibiting both IL-1α and IL-1β. This compound is under investigation for its potential application in osteoarthritis research [1].
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
ARP3138-01 10 µg
Recombinant Human Neuron-Specific Enolase (NSE) Protein
Sign In for Pricing
View Details ARP3138-02 50 µg
Recombinant Human Neuron-Specific Enolase (NSE) Protein
Sign In for Pricing
View Details ARP3138-03 100 µg
Recombinant Human Neuron-Specific Enolase (NSE) Protein
Sign In for Pricing
View Details ARP3138-04 1 mg
Recombinant Human Neuron-Specific Enolase (NSE) Protein
Sign In for Pricing
View Details 
426718-01 10 mg
3,16-Bis (2,2-dimethylpropanoate) -estra-1,3,5 (10) -trien-17-one
Sign In for Pricing
View Details